A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Regorafenib
Related studies linked through entity extraction aliases.
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
- Status
- UNKNOWN
- Phase
- PHASE2
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting
- Status
- COMPLETED
- Phase
- N/A
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
- Status
- UNKNOWN
- Phase
- PHASE2
Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib
- Status
- COMPLETED
- Phase
- NA
Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ruxolitinib in Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2